REG - Kromek Group PLC - Grant of Options, PDMR Dealings and TVR
Tue 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251028:nRSb0188Fa&default-theme=true
RNS Number : 0188F Kromek Group PLC 28 October 2025
28 October 2025
Kromek Group plc
("Kromek", the "Company" or the "Group")
Grant of Options, PDMR Dealings
and
Total Voting Rights
Kromek (AIM: KMK), a global detection company delivering best-in-class
solutions for the advanced imaging and CBRN detection markets, announces the
following grant of options to, and exercise of options by, directors of the
Company.
Grant of options
On 27 October 2025 (the "Grant Date"), the Company granted options over
ordinary shares of 1p each in the Company ("Ordinary Shares") to the directors
of the Company in consideration for certain bonus awards and salary increases
as detailed below. The directors elected to receive options in lieu of cash
payments to support the Company's cash position and to further align the
interests of the directors with those of shareholders.
Director Number of options Exercise price Vesting period((1))
Arnab Basu, CEO 1,111,375((2)) 1p Vest upon issue
469,355((3) (7)) 1p 234,677 options vest upon issue and the remainder vest in six equal
installments on the monthly anniversary of the Grant Date subject to Dr. Basu
remaining a director of the Company
Berry Beumer, COO & President of Advanced Imaging Division 1,111,375((2)) 1p Vest upon issue
Claire Burgess, CFO 1,500,000((4)) 5.6p 50% of the options vest on the second annual anniversary of the Grant Date and
50% vest on the third annual anniversary of the Grant subject to Ms. Burgess
remaining a director of the Company
Rakesh Sharma, Chairman 59,033((5) (7)) 1p 29,516 options vest upon issue and the remainder vest in six equal
installments on the monthly anniversary of the Grant Date subject to Mr.
Sharma remaining a director of the Company
Christopher Wilkes, Non-executive Director 31,104((5) (7)) 1p 15,552 options vest upon issue and the remainder vest in six equal
installments on the monthly anniversary of the Grant Date subject to Mr.
Wilkes remaining a director of the Company
Lawrence Kinet, Non-executive Director 14,352((6) (7)) 1p Vest upon issue
Jerel Whittingham, Non-executive Director 15,552((6) (7)) 1p Vest upon issue
Notes
(1) All of the options, to the extent vested, expire on the tenth annual
anniversary of the Grant Date.
(2) Options granted in respect of the delivery of the second milestone under
the Company's enablement agreement with Siemens Healthineers and receipt of
the associated cash payment, as described in the Company's announcement of 16
September 2025. The quantity of options was calculated based on a price of
5.65p per Ordinary Share, being the average price of the Company's Ordinary
Shares on AIM for the three months preceding and three months following the
announcement of the Siemens Healthineers transaction on 30 January 2025.
(3) Options granted in lieu of salary increases for the financial years
ending 30 April 2025 and 30 April 2026, with the percentage increase matching
that given to the Company's employees for the same period.
(4) Options granted as a special bonus for success in securing the Company's
new banking facilities and in completing the audit for the financial year
ended 30 April 2025. The exercise price represents the average price of the
Company's Ordinary Shares on AIM for the period from 12 May 2025, being the
date Ms. Burgess joined the Company, to 16 September 2025, being the date of
the announcement of the Company's final results for the ended 30 April 2025.
(5) Options granted in lieu of salary increases for the financial year
ending 30 April 2026, with the percentage increase matching that given to the
Company's employees for the same period.
(6) Options granted in lieu of salary increases for the financial year
ending 30 April 2026, with the percentage increase matching that given to the
Company's employees for the same period. Mr. Kinet and Mr. Whittingham were
granted the options as Non-executive Directors ahead of resigning from their
positions at the conclusion of the annual general meeting on 27 October 2025.
Accordingly, their options cover the period from 1 May 2025 to their
resignation.
(7) The quantity of options was calculated based on a price of 5.8p per
Ordinary Share, being the average price of the Company's Ordinary Shares on
AIM for the period from 1 May 2025 to 31 July 2025.
Exercise of options
The Company also announces that, on 27 October 2025, Arnab Basu, Chief
Executive Officer, exercised options over 110,000 Ordinary Shares at a price
of 1p per Ordinary Share.
Following this exercise of options, Dr. Basu has an interest in 3,198,750
Ordinary Shares representing 0.5% of the Company's enlarged issued share
capital and holds options over 9,287,308 Ordinary Shares.
Board structure
Following the conclusion of yesterday's annual general meeting, Lawrence Kinet
and Jerel Whittingham have retired from the Board and Matthew ("Matt") Boyle
has joined as a Non-executive Director of the Company.
Total voting rights
Application has been made to the London Stock Exchange for the 110,000
Ordinary Shares to be admitted to trading on AIM ("Admission") and it is
expected that Admission will become effective at 8:00 a.m. on or around 31
October 2025. The new Ordinary Shares will rank pari passu with the
existing Ordinary Shares in the Company.
Following Admission, the total number of Ordinary Shares in issue will be
655,096,840. This figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, the share capital of the
Company under the Financial Conduct Authority's Disclosure Guidance and
Transparency Rules. Following the issue of options to directors, the Company
has options outstanding over 41,247,868 Ordinary Shares, which following
Admission will represent 6.3% of the Company's enlarged issued share capital.
This announcement contains inside information for the purposes of Article 7 of
Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of
the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in
accordance with the Company's obligations under Article 17 of MAR.
Enquiries
Kromek Group plc
Arnab Basu, CEO +44 (0)1740 626 060
Claire Burgess, CFO
Cavendish Capital Markets Limited (Nominated Adviser and Broker)
Geoff Nash/Giles Balleny/Seamus Fricker - Corporate Finance +44 (0)20 7220 0500
Tim Redfern - ECM
Michael Johnson - Sales
Gracechurch Group (Financial PR)
Harry Chathli/Claire Norbury +44 (0)20 4582 3500
Kromek Group plc
Kromek Group plc is a leading developer of radiation detection and
bio-detection technology solutions for the advanced imaging and CBRN detection
segments. Headquartered in County Durham, UK, Kromek has manufacturing
operations in the UK and US, delivering on the vision of enhancing the quality
of life through innovative detection technology solutions.
The advanced imaging segment comprises the medical (including CT and SPECT),
security and industrial markets. Kromek provides its OEM customers with
detector components, based on its core cadmium zinc telluride (CZT) platform,
to enable better detection of diseases such as cancer and Alzheimer's,
contamination in industrial manufacture and explosives in aviation
settings.
In CBRN detection, the Group provides nuclear radiation detection solutions
to the global homeland defence and security market. Kromek's compact,
handheld, high-performance radiation detectors, based on advanced
scintillation and solid-state readout technology, are primarily used to
protect critical infrastructure, events, personnel and urban environments from
the threat of 'dirty bombs'.
The Group is also developing bio-security solutions in the CBRN detection
segment. These consist of fully automated and autonomous systems to detect a
wide range of airborne pathogens.
Kromek is listed on AIM, a market of the London Stock Exchange, under the
trading symbol 'KMK'.
Notification and public disclosure of transactions by persons discharging managerial
responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Arnab Basu
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Kromek Group plc
b) LEI 213800VLHYXGHEX5VQ48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options over ordinary shares of 1 penny each
Identification code GB00BD7V5D43
b) Nature of the transaction 1. Grants of options
2. Exercise of options
c) Price(s) and volume(s)
Price(s) Volume(s)
1. 1p 1,111,375 (grant)
1. 1p 469,355 (grant)
2. 1p 110,000 (exercise)
d)
Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 27 October 2025
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Berry Beumer
2 Reason for the notification
a) Position/status Chief Operating Officer and President of the Advanced Imaging Division
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Kromek Group plc
b) LEI 213800VLHYXGHEX5VQ48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options over ordinary shares of 1 penny each
Identification code GB00BD7V5D43
b) Nature of the transaction Grant of options
c) Price(s) and volume(s)
Price(s) Volume(s)
1p 1,111,375
d)
Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 27 October 2025
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Claire Burgess
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Kromek Group plc
b) LEI 213800VLHYXGHEX5VQ48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options over ordinary shares of 1 penny each
Identification code GB00BD7V5D43
b) Nature of the transaction Grant of options
c) Price(s) and volume(s)
Price(s) Volume(s)
5.6p 1,500,000
d)
Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 27 October 2025
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Rakesh Sharma
2 Reason for the notification
a) Position/status Chairman
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Kromek Group plc
b) LEI 213800VLHYXGHEX5VQ48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options over ordinary shares of 1 penny each
Identification code GB00BD7V5D43
b) Nature of the transaction Grant of options
c) Price(s) and volume(s)
Price(s) Volume(s)
1p 59,033
d)
Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 27 October 2025
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Christopher Wilkes
2 Reason for the notification
a) Position/status Non-executive Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Kromek Group plc
b) LEI 213800VLHYXGHEX5VQ48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options over ordinary shares of 1 penny each
Identification code GB00BD7V5D43
b) Nature of the transaction Grant of options
c) Price(s) and volume(s)
Price(s) Volume(s)
1p 31,104
d)
Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 27 October 2025
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Lawrence Kinet
2 Reason for the notification
a) Position/status Non-executive Director (at the time of the transaction)
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Kromek Group plc
b) LEI 213800VLHYXGHEX5VQ48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options over ordinary shares of 1 penny each
Identification code GB00BD7V5D43
b) Nature of the transaction Grant of options
c) Price(s) and volume(s)
Price(s) Volume(s)
1p 14,352
d)
Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 27 October 2025
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Jerel Whittingham
2 Reason for the notification
a) Position/status Non-executive Director (at the time of the transaction)
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Kromek Group plc
b) LEI 213800VLHYXGHEX5VQ48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options over ordinary shares of 1 penny each
Identification code GB00BD7V5D43
b) Nature of the transaction Grant of options
c) Price(s) and volume(s)
Price(s) Volume(s)
1p 15,552
d)
Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 27 October 2025
f) Place of the transaction Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFDLLLEBLBFBE
Copyright 2019 Regulatory News Service, all rights reservedRecent news on Kromek
See all newsREG - Kromek Group PLC - Grant of Options, PDMR Dealings and TVR
AnnouncementREG - Kromek Group PLC - Result of AGM
AnnouncementREG - Kromek Group PLC - Pre-close Trading Statement
AnnouncementREG - Kromek Group PLC - Notice of AGM and Publication of Annual Report
AnnouncementREG - Kromek Group PLC - Final Results
Announcement